Search for: "Kirin v. Kirin"
Results 21 - 40
of 83
Sort by Relevance
|
Sort by Date
26 Jul 2017, 3:49 am
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]
26 Jul 2017, 3:49 am
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]
17 Jul 2017, 3:39 pm
This GuestKat has noted with interest comments which suggest that this case opens the way to a doctrine of "file wrapper estoppel" in the UK, but wonders whether the case really goes much further than existing UK case law which has admitted reference to the file in cases of "admissions against interest" - see for example Rohm & Haas v Collag [2002] F.S.R. 28 and Furr v Truline [1985] F.S.R. 553. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
13 Jul 2017, 8:47 am
The judgment comes as a surprise, as the previously established UK case law had over time firmly done away with the idea of ‘pith and marrow’ infringement, culminating in the seminal House of Lords judgment in Kirin-Amgen v Hoechst Marion Roussel [2004] UKHL 46. [read post]
12 Jul 2017, 1:34 pm
It is here - the Supreme Court's decision in Eli Lilly v Actavis UK [2017] UKSC 48. [read post]
12 Jul 2017, 7:59 am
Eli Lilly v Actavis UK [2017] UKSC 48This is an important case about whether drugs manufactured by Actavis infringe a European patent of Lilly. [read post]
2 May 2017, 6:45 pm
Here's some fun with offers from Kirin Produce Co. v. [read post]
30 Apr 2017, 4:30 am
Fujifilm v AbbVie: practice, procedure and policy analysisGuest Kat Eibhlin Vardy summarizes the Rapid Response event organized by AIPPI on the case Fujifilm Kyowa Kirin Biologics Company Limited v AbbVie Biotechnology Limited, [2017] EWHC 395 (Pat), from the perspective of patent and competition law.Overturning a trade mark opposition decision - Part 2 - SOULUXE - likelihood of confusionGuest Kat Rosie Burbidge recaps the case SoulCycle Inc v Matalan Ltd,… [read post]
19 Apr 2017, 2:21 am
Much of the hearing was therefore taken up by submissions on the proper approach to take on claim construction in view of EPC 2000 and the seminal UK cases of Catnic [1982] R.P.C. 183, Improver [1990] F.S.R. 181 and Kirin-Amgen [2004] UKHL 46. [read post]
13 Mar 2017, 3:12 am
On 2 March, the AmeriKat, as a keen prowler of the Daily Cause list, warms up for the following day’s court decision in the first trial between Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited by summarising the latest timeline events.BREAKING: High Court grants declaration that products obvious/anticipated at claimed priority datesFollowing AmeriKat’s notice, Eibhlin Vardy timely analysed the High Court’s decision… [read post]
8 Mar 2017, 9:26 am
On 2 March, the AmeriKat, as a keen prowler of the Daily Cause list, warms up for the following day’s court decision in the first trial between Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited by summarising the latest timeline events.BREAKING: High Court grants declaration that products obvious/anticipated at claimed priority datesFollowed AmeriKat’s notice, Eibhlin Vardy timely analyzes the High Court’s decision on 3 March that… [read post]
3 Mar 2017, 7:25 am
The High Court has granted declarations to FKB and SB to the effect that their products lacked novelty or an inventive step at a particular date - Fujifilm Kyowa Kirin Biologics Company Limited and Samsung Bioepsis UK Limited v AbbVie Biotechnology Limited [2017] EWHC 395 (Pat). [read post]
2 Mar 2017, 1:02 pm
Readers are in for a treat as tomorrow Mr Justice Carr's decision in the first trial between Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited ("FKB 1") is being handed down at 10:30AM London time.As soon as we digest the decision, GuestKat Eihblin Vardy, will be back to let readers know whether, despite having survived various interim attempts by AbbVie to kill it, the Arrow declaration has finally hit the target for… [read post]
25 Jan 2017, 10:48 pm
Andrew considered that Regeneron v Kymab [2016] EWHC 87 (Pat) represented the most technically difficult decision of the year, although he noted that Electromagnetic Geoservices v PGS would have run it pretty close had the case not settled. [read post]
22 Jan 2017, 11:49 am
Seeking an ArrowArrow declarations can be granted: Fujifilm v AbbVieGuestKat Eibhlin Vardy discusses Fujifilm Kyowa Kirin Biologics Co., Ltd v AbbVie Biotechnology Ltd & Anor [2017] EWCA Civ 1, which involves two appeals, both raising the question of whether a Court can grant a so called ‘Arrow declaration’, i.e. a declaration that “a product was old or obvious in patent law terms at a particular date”.Guest Post - China's Patent… [read post]
18 Jan 2017, 3:34 am
Qiao Yongzhong's book “Maintenance time and the industry development of patents -- empirical research with evidence from China”Biosimilars battle in clearing the way - Fujifilm v AbbVie continuesFull low down on the interim decision handed down by Mr Justice Carr on 29 December in the biosimilars battle of Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited [2016] EWHC 3383 (Ch).15 fully-funded IP PhD positions are calling for… [read post]
13 Jan 2017, 9:24 am
The Court of Appeal decided yesterday that the High Court can, as a point of principle, properly grant declarations that a product lacked novelty or an inventive step at a particular date, see Fujifim Kyowa Kirin Biologics Co., Ltd v AbbVie Biotechnology Limited and Others [2017] EWCA Civ 1. [read post]
5 Jan 2017, 4:11 am
While many of us were recovering from excessive helpings of turkey and Christmas pudding, a fascinating interim decision was handed down by Mr Justice Carr on 29 December in the biosimilars battle of Fujifilm Kyowa Kirin Biologics Co., Ltd and Others v AbbVie Biotechnology Limited [2016] EWHC 3383 (Ch). [read post]
11 Apr 2016, 2:38 am
Batman v. [read post]
